A citation-based method for searching scientific literature


List of co-cited articles
9 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Clinical Next Generation Sequencing for Precision Medicine in Cancer.
Ling Dong, Wanheng Wang, Alvin Li, Rina Kansal, Yuhan Chen, Hong Chen, Xinmin Li. Curr Genomics 2015
37
27

Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.
Lawrence J Jennings, Maria E Arcila, Christopher Corless, Suzanne Kamel-Reid, Ira M Lubin, John Pfeifer, Robyn L Temple-Smolkin, Karl V Voelkerding, Marina N Nikiforova. J Mol Diagn 2017
210
27

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
Hui Gao, Joshua M Korn, Stéphane Ferretti, John E Monahan, Youzhen Wang, Mallika Singh, Chao Zhang, Christian Schnell, Guizhi Yang, Yun Zhang,[...]. Nat Med 2015
538
18

A decision support framework for genomically informed investigational cancer therapy.
Funda Meric-Bernstam, Amber Johnson, Vijaykumar Holla, Ann Marie Bailey, Lauren Brusco, Ken Chen, Mark Routbort, Keyur P Patel, Jia Zeng, Scott Kopetz,[...]. J Natl Cancer Inst 2015
116
18

The challenge of intratumour heterogeneity in precision medicine.
J Seoane, L De Mattos-Arruda. J Intern Med 2014
42
18

Sequencing technologies - the next generation.
Michael L Metzker. Nat Rev Genet 2010
18

Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers.
Nicky D'Haene, Marie Le Mercier, Nancy De Nève, Oriane Blanchard, Mélanie Delaunoy, Hakim El Housni, Barbara Dessars, Pierre Heimann, Myriam Remmelink, Pieter Demetter,[...]. PLoS One 2015
47
18




Limits to Personalized Cancer Medicine.
Ian F Tannock, John A Hickman. N Engl J Med 2016
190
9

Circos: an information aesthetic for comparative genomics.
Martin Krzywinski, Jacqueline Schein, Inanç Birol, Joseph Connors, Randy Gascoyne, Doug Horsman, Steven J Jones, Marco A Marra. Genome Res 2009
9

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.
Takahito Nakahara, Aya Kita, Kentaro Yamanaka, Masamichi Mori, Nobuaki Amino, Masahiro Takeuchi, Fumiko Tominaga, Shinji Hatakeyama, Isao Kinoyama, Akira Matsuhisa,[...]. Cancer Res 2007
317
9

YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer.
Fredrik Jerhammar, Ann-Charlotte Johansson, Rebecca Ceder, Jenny Welander, Agneta Jansson, Roland C Grafström, Peter Söderkvist, Karin Roberg. Oral Oncol 2014
33
9

Patient-derived tumour xenografts as models for breast cancer drug development.
Elisabetta Marangoni, Marie-France Poupon. Curr Opin Oncol 2014
24
9

Lessons from patient-derived xenografts for better in vitro modeling of human cancer.
Stephen Yiu Chuen Choi, Dong Lin, Peter W Gout, Colin C Collins, Yong Xu, Yuzhuo Wang. Adv Drug Deliv Rev 2014
99
9

Precision oncology: origins, optimism, and potential.
Vinay Prasad, Tito Fojo, Michael Brada. Lancet Oncol 2016
94
9

LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets.
Andreas Wilm, Pauline Poh Kim Aw, Denis Bertrand, Grace Hui Ting Yeo, Swee Hoe Ong, Chang Hua Wong, Chiea Chuen Khor, Rosemary Petric, Martin Lloyd Hibberd, Niranjan Nagarajan. Nucleic Acids Res 2012
456
9

The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform.
Amber Johnson, Jia Zeng, Ann M Bailey, Vijaykumar Holla, Beate Litzenburger, Humberto Lara-Guerra, Gordon B Mills, John Mendelsohn, Kenna R Shaw, Funda Meric-Bernstam. Drug Discov Today 2015
41
9

SpDamID: Marking DNA Bound by Protein Complexes Identifies Notch-Dimer Responsive Enhancers.
Matthew R Hass, Hien-Haw Liow, Xiaoting Chen, Ankur Sharma, Yukiko U Inoue, Takayoshi Inoue, Ashley Reeb, Andrew Martens, Mary Fulbright, Saravanan Raju,[...]. Mol Cell 2015
28
9

Prospective derivation of a living organoid biobank of colorectal cancer patients.
Marc van de Wetering, Hayley E Francies, Joshua M Francis, Gergana Bounova, Francesco Iorio, Apollo Pronk, Winan van Houdt, Joost van Gorp, Amaro Taylor-Weiner, Lennart Kester,[...]. Cell 2015
870
9

β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis.
Joseph Rosenbluh, Deepak Nijhawan, Andrew G Cox, Xingnan Li, James T Neal, Eric J Schafer, Travis I Zack, Xiaoxing Wang, Aviad Tsherniak, Anna C Schinzel,[...]. Cell 2012
447
9

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
9

Trial watch: Phase II failures: 2008-2010.
John Arrowsmith. Nat Rev Drug Discov 2011
355
9

Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivin.
Naoto Nakamura, Tomohiro Yamauchi, Masashi Hiramoto, Masatoshi Yuri, Masanori Naito, Masahiro Takeuchi, Kentaro Yamanaka, Aya Kita, Takahito Nakahara, Isao Kinoyama,[...]. Mol Cell Proteomics 2012
49
9

Clinical approval success rates for investigational cancer drugs.
J A DiMasi, J M Reichert, L Feldman, A Malins. Clin Pharmacol Ther 2013
85
9

Docetaxel enhances tumor radioresponse in vivo.
K A Mason, N R Hunter, M Milas, J L Abbruzzese, L Milas. Clin Cancer Res 1997
97
9

Sepantronium bromide (YM155) induces disruption of the ILF3/p54(nrb) complex, which is required for survivin expression.
Tomohiro Yamauchi, Naoto Nakamura, Masashi Hiramoto, Masatoshi Yuri, Hiroyuki Yokota, Masanori Naitou, Masahiro Takeuchi, Kentaro Yamanaka, Aya Kita, Takahito Nakahara,[...]. Biochem Biophys Res Commun 2012
52
9

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.
Elisa M Noll, Christian Eisen, Albrecht Stenzinger, Elisa Espinet, Alexander Muckenhuber, Corinna Klein, Vanessa Vogel, Bernd Klaus, Wiebke Nadler, Christoph Rösli,[...]. Nat Med 2016
98
9

Uniform, optimal signal processing of mapped deep-sequencing data.
Vibhor Kumar, Masafumi Muratani, Nirmala Arul Rayan, Petra Kraus, Thomas Lufkin, Huck Hui Ng, Shyam Prabhakar. Nat Biotechnol 2013
89
9

The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma.
Weiwei Zhai, Tony Kiat-Hon Lim, Tong Zhang, Su-Ting Phang, Zenia Tiang, Peiyong Guan, Ming-Hwee Ng, Jia Qi Lim, Fei Yao, Zheng Li,[...]. Nat Commun 2017
58
9

A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.
Alejandra Bruna, Oscar M Rueda, Wendy Greenwood, Ankita Sati Batra, Maurizio Callari, Rajbir Nath Batra, Katherine Pogrebniak, Jose Sandoval, John W Cassidy, Ana Tufegdzic-Vidakovic,[...]. Cell 2016
187
9

Cytoscape: a software environment for integrated models of biomolecular interaction networks.
Paul Shannon, Andrew Markiel, Owen Ozier, Nitin S Baliga, Jonathan T Wang, Daniel Ramage, Nada Amin, Benno Schwikowski, Trey Ideker. Genome Res 2003
9

Development and clinical application of an integrative genomic approach to personalized cancer therapy.
Andrew V Uzilov, Wei Ding, Marc Y Fink, Yevgeniy Antipin, Andrew S Brohl, Claire Davis, Chun Yee Lau, Chetanya Pandya, Hardik Shah, Yumi Kasai,[...]. Genome Med 2016
46
9

Uncertainty in the Era of Precision Medicine.
David J Hunter. N Engl J Med 2016
63
9

An eleven gene molecular signature for extra-capsular spread in oral squamous cell carcinoma serves as a prognosticator of outcome in patients without nodal metastases.
Weining Wang, Weng Khong Lim, Hui Sun Leong, Fui Teen Chong, Tony K H Lim, Daniel S W Tan, Bin Tean Teh, N Gopalakrishna Iyer. Oral Oncol 2015
37
9

Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations.
Francesca Ricci, Francesca Bizzaro, Marta Cesca, Federica Guffanti, Monica Ganzinelli, Alessandra Decio, Carmen Ghilardi, Patrizia Perego, Robert Fruscio, Alessandro Buda,[...]. Cancer Res 2014
71
9

Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance.
Andre Luiz Vettore, Kalpana Ramnarayanan, Gregory Poore, Kevin Lim, Choon Kiat Ong, Kie Kyon Huang, Hui Sun Leong, Fui Teen Chong, Tony Kiat-Hon Lim, Weng Khong Lim,[...]. Genome Med 2015
49
9

Personalized genomic analyses for cancer mutation discovery and interpretation.
Siân Jones, Valsamo Anagnostou, Karli Lytle, Sonya Parpart-Li, Monica Nesselbush, David R Riley, Manish Shukla, Bryan Chesnick, Maura Kadan, Eniko Papp,[...]. Sci Transl Med 2015
223
9

Trial watch: phase II and phase III attrition rates 2011-2012.
John Arrowsmith, Philip Miller. Nat Rev Drug Discov 2013
307
9

Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor.
William McLaren, Bethan Pritchard, Daniel Rios, Yuan Chen, Paul Flicek, Fiona Cunningham. Bioinformatics 2010
9

Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter.
Qiuying Cheng, Xiang Ling, Andrew Haller, Takahito Nakahara, Kentaro Yamanaka, Aya Kita, Hiroshi Koutoku, Masahiro Takeuchi, Michael G Brattain, Fengzhi Li. Int J Biochem Mol Biol 2012
69
9

Defining actionable mutations for oncology therapeutic development.
T Hedley Carr, Robert McEwen, Brian Dougherty, Justin H Johnson, Jonathan R Dry, Zhongwu Lai, Zara Ghazoui, Naomi M Laing, Darren R Hodgson, Francisco Cruzalegui,[...]. Nat Rev Cancer 2016
52
9

Patient-derived models of acquired resistance can identify effective drug combinations for cancer.
Adam S Crystal, Alice T Shaw, Lecia V Sequist, Luc Friboulet, Matthew J Niederst, Elizabeth L Lockerman, Rosa L Frias, Justin F Gainor, Arnaud Amzallag, Patricia Greninger,[...]. Science 2014
415
9

Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
N Gopalakrishna Iyer, Daniel S W Tan, Veronique K M Tan, Weining Wang, Jacqueline Hwang, Ngian-Chye Tan, Ranjiv Sivanandan, Hiang-Khoon Tan, Wan Teck Lim, Mei-Kim Ang,[...]. Cancer 2015
73
9

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.
Kristian Cibulskis, Michael S Lawrence, Scott L Carter, Andrey Sivachenko, David Jaffe, Carrie Sougnez, Stacey Gabriel, Matthew Meyerson, Eric S Lander, Gad Getz. Nat Biotechnol 2013
9

The Sequence Alignment/Map format and SAMtools.
Heng Li, Bob Handsaker, Alec Wysoker, Tim Fennell, Jue Ruan, Nils Homer, Gabor Marth, Goncalo Abecasis, Richard Durbin. Bioinformatics 2009
9

The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
Aaron McKenna, Matthew Hanna, Eric Banks, Andrey Sivachenko, Kristian Cibulskis, Andrew Kernytsky, Kiran Garimella, David Altshuler, Stacey Gabriel, Mark Daly,[...]. Genome Res 2010
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.